Atlas Trials

Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)

Clinical trial NCT01822691 · COMPLETED

Trial details

NCT number
NCT01822691
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2013-07-01
Primary completion
2015-01-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.